What is Panacea Life Sciences Holdings Probability of Financial Distress (%)?
Probability of Financial Distress (%) measures the probability that a company will go bankrupt in the upcoming year given its current financial position. A higher ratio indicates a larger probability of bankruptcy for the company, while a lower ratio indicates a healthier fundamental. As of today, Panacea Life Sciences Holdings's Probability of Financial Distress (%) is 12.99%.
Like the Altman Z-Score, the PFD measures a company's bankruptcy risk. However, the main drawback of the Z-score is it does not apply to banks and insurance companies. According to Investopedia, the concept of "working capital" does not apply to banks and insurance companies, as financial institutions do not have typical current assets or current liabilities like inventories or accounts payable.
Competitive Comparison of Panacea Life Sciences Holdings's Probability of Financial Distress (%)
For the Drug Manufacturers - Specialty & Generic subindustry, Panacea Life Sciences Holdings's Probability of Financial Distress (%), along with its competitors' market caps and Probability of Financial Distress (%) data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Panacea Life Sciences Holdings's Probability of Financial Distress (%) Distribution in the Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Panacea Life Sciences Holdings's Probability of Financial Distress (%) distribution charts can be found below:
* The bar in red indicates where Panacea Life Sciences Holdings's Probability of Financial Distress (%) falls into.
Panacea Life Sciences Holdings Probability of Financial Distress (%) Calculation
Probability of Financial Distress (%) (PFD) was developed by John Campbell, Jens Hilscher and Jan Szilagyi in their Search of Distress Risk. It measures the probability that a company will go bankrupt within the next 12 months given its current financial position.
The Probability of Financial Distress (%) was obtained by a logit probability model based on eight explanatory variables. The logit formula to compute the probability of financial distress (LPFD) is given below:
| LPFD | = | -20.12 * NIMTAAVG | + | 1.60 * TLMTA | - | 7.88 * EXRETAVG | + | 1.55 * SIGMA | - | 0.005 * RSIZE | - | 2.27 * CASHMTA | + | 0.070 * MB | - | 0.09 * PRICE | - | 8.87 |
| = | -1.90 |
The Probability of Financial Distress (%) (PFD) was then obtianed by:
| PFD | = | 1 | / | (1 + e^(-LPFD)) | * | 100% |
| = | 12.99% |
The eight explanatory variables are:
1. NIMTAAVG = Net Income to Market Total Assets
*Note that for companies reported quarterly, geometrically declining weighted quarterly Net Income data in latest four quarters are used.
2. TLMTA = Total liabilities to Market Total Assets
3. CASHMTA = Cash to Market Total Assets
For non-financial companies, CASHMTA is measured as:
4. EXRETAVG = Excess Return compared to the S&P 500
EXRETAVG is the weighted excess return compared to the S&P 500 in past 12 month. Geometrically declining weights are imposed on the monthly excess return to reflect lagged information. The weight is halved each quarter.
5. SIGMA = Standard Deviation of Daily Returns
For sigma, we use the annualized standard deviation of a company's returns over the past 92 days (or 63 trading days).
6. RSIZE = Relative Size
| RSIZE | = | log (Market Cap | / | Total Market Cap of S&P 500 companies) |
7. MB = Market to Adjusted Book Equity Ratio
8. PRICE
PRICE is measured as the log of the stock price, capped at log(15).
Panacea Life Sciences Holdings (Panacea Life Sciences Holdings) Business Description
Traded in Other Exchanges
N/A
Address
5910 S University Boulevard, C18-193, Greenwood Village, CO, USA, 80121
Panacea Life Sciences Holdings Inc is a cannabinoid nutraceutical manufacturer and research company that produces natural pharmaceutical alternatives for consumers and pets. It manufactures and sells soft gels, gummies, tinctures, sublingual tablets, cosmetics, and other topicals.
Executives
| Leslie Buttorff |
director, 10 percent owner, officer: CHIEF EXECUTIVE OFFICER |
16194 W 45TH DRIVE, GOLDEN CO 80403 |
| Janice Nerger |
director |
5910 S UNIVERSITY BLVD., C18-193, GREENWOOD VILLAGE CO 80121 |
| Nathan Joel Berman |
officer: CONTROLLER & PRIN ACTNG OFCR |
16194 W 45TH DRIVE, GOLDEN CO 80403 |
| 22nd Century Group, Inc. |
10 percent owner |
8560 MAIN STREET, SUITE 4, WILLIAMSVILLE NY 14221 |
| Harvey J Kesner |
10 percent owner |
65 E. 55TH STREET, NEW YORK NY 10022 |
| Lawrence Wert |
director |
170 NUTTALL RD, RIVERSIDE IL 60546 |
| Chesne Derek Du |
officer: Chief Growth Officer |
80 NE 4TH AVENUE, SUITE 28, DELRAY BEACH FL 33483 |
| Alvaro Daniel Alberttis |
director |
80 NE 4TH AVENUE, SUITE 28, DELRAY BEACH FL 33483 |
| Vladislav Yampolsky |
director, 10 percent owner |
332 PLAZA REAL, BOCA RATON FL 33432 |
| Steven A Schwartz |
director |
332 PLAZA REAL, BOCA RATON FL 33432 |
| Andrew L. Johnson |
officer: Chief Strategy Officer |
80 NE 4TH AVE. SUITE 28, DELRAY BEACH FL 33483 |
| Emiliano Angel Aloi |
officer: President |
510 SUNSHINE DRIVE, DELRAY BEACH FL 33444 |
| Jonathan Gilbert |
director, officer: Executive Chairman |
36 SYCAMORE LANE, ROSALYN HEIGHTS NY 11577 |
| John C Price |
director |
4721 IRONTON STREET, BUILDING A, DENVER CO 80239 |
| Kevin James Esval |
director |
NEURO HITECH INC, ONE PENN PLAZA STE 1503, NEW YORK NY 10019 |
Panacea Life Sciences Holdings (Panacea Life Sciences Holdings) Headlines
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
PLSH has been successfully added to your